← FDA Drug Approvals (Drugs@FDA)

ELIXICON

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FOREST LABS

Drug application

FDA Application #
ANDA085502
Application type
Abbreviated New Drug Application (Generic)
Brand name
ELIXICON
Generic name
Theophylline
Active ingredients
THEOPHYLLINE
Dosage form
SUSPENSION
Route
ORAL
Marketing status
Discontinued
Sponsor
FOREST LABS

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown